CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 120 enrolled
Drug / intervention
BLI4700drug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03023085
NCT03023085Phase 2Completed

A Pilot Evaluation of BLI4700 Bowel Preparation in Adult Subjects

Braintree Laboratories·interventional·Posted Jan 18, 2017·Updated Nov 15, 2023

In Brief

A Phase 2 clinical trial evaluating BLI4700 for Colonoscopy. Completed, enrolled 120 participants across 1 site.

Detailed Summary

The objective of this study is to evaluate the safety and efficacy of BLI4700 as a bowel preparation prior to colonoscopy in adult patients.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsColonoscopy
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
2017201820192020202120222023202420252026
First PostedJan 18, 2017
Enrollment StartAug 1, 2016
Primary CompletionAug 1, 2017
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 9.5 years ago

Interventions

BLI4700drug

BLI4700 bowel preparation